Abstract
Purpose
To explore whether newly diagnosed type 2 diabetes patients without previous cardiovascular disease (CVD) initiate preventive statin therapy regardless of ethnic background.
Methods
Using nationwide individual-level registers, we followed a cohort of Danish-born residents and immigrants from Turkey, Pakistan and Ex-Yugoslavia, all without previous diabetes or CVD, during the period 2000–2008 for first dispensing of oral glucose-lowering medication (GLM), first dispensing of statins and register-markers of CVD (N = 3,764,620). Logistic regression analyses were used to test whether the odds ratios (ORs) of early statin therapy initiation (within 180 days after first GLM dispensing) are the same regardless of ethnic background. While age and gender were included as confounders in the basic model, income was included in the second model as a potential mediating variable.
Results
Compared to native Danes, the ORs for early statin therapy were 0.68 (95 % confidence interval 0.50–0.92], 0.67 (0.56–0.81) and 0.56 (0.44–0.71) for Ex-Yugoslavians, Turks and Pakistanis, respectively. The differences remained largely unchanged after adjusting for income and tended to be accentuated when the threshold period was extended. The ORs of women initiating therapy (compared to native Danes) were 0.56 (0.35–0.90), 0.60 (0.46–0.78) and 0.48 (0.32–0.72) for Ex-Yugoslavians, Turks and Pakistanis, respectively, and those for men were 0.78 (0.52–1.17), 0.74 (0.58–0.95) and 0.60 (0.44–0.83), respectively.
Conclusions
Immigrants from Turkey, Pakistan and Ex-Yugoslavia with type 2 diabetes were less likely to initiate statin therapy than Danish-born residents—despite a similar or even higher risk of CVD. The treatment inequities associated with ethnicity were more pronounced in women than men.
Similar content being viewed by others
References
Bruno G, Landi A (2011) Epidemiology and costs of diabetes. Transplant Proc 43(1):327–329
Rathmann W, Giani G (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(10):2568–2569
Kristensen JK, Bak JF, Wittrup I, Lauritzen T (2007) Diabetes prevalence and quality of diabetes care among Lebanese or Turkish immigrants compared to a native Danish population. Prim Care Diabetes 1(3):159–165
Wandell PE, Johansson SE, Gafvels C, Hellenius ML, de Faire U, Sundquist J (2008) Estimation of diabetes prevalence among immigrants from the Middle East in Sweden by using three different data sources. Diabetes Metab 34(4 Pt 1):328–333
Oza-Frank R, Narayan KM (2010) Overweight and diabetes prevalence among US immigrants. Am J Public Health 100(4):661–668
World Health Organization (2011) Diabetes fact sheet number 12. Available at:http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed 01 Feb 2012
Resnick HE, Howard BV (2002) Diabetes and cardiovascular disease. Annu Rev Med 53:245–267
Ting RZ, Yang X, Yu LW, Luk AO, Kong AP, So WY et al (2010) Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study. Cardiovasc Diabetol 9:77
Kojima S, Sakamoto T, Ogawa H, Kitagawa A, Matsui K, Hea S (2010) Standard-dose statin therapy provides incremental clinical benefits in normocholesterolemic diabetic patients. Circ J 74(4):779–785
Heart Protection Study Collaborative Group (2002) MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326):7–22
Færgemann O, Christensen B, Hansen HS et al (2000) Sekundær og primær forebyggelse af koronar hjertesygdom med særligt henblik på dyslipidæmi [secondary and primary prevention of coronar heart disease with special reference to dyslipidemia]. Danish Society of Cardiology (DSC), Copenhagen
National Institute for Health and Clinical Excellence (2009) The management of type 2 diabetes. Diabetes CG87. National Institutes of Health, Bethesda
Association AD (2008) Standards of medical care in diabetes. Diabetes Care 31[Suppl 1]:S12–S54
Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ et al (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28(1):88–136
Statistics Denmark (2011) Immigrants in Denmark. Copenhagen, Statistics Denmark
Leif H (2001) Employment and wage assimilation of male first-generation immigrants in Denmark. Int J Manpow 22(½):39–68
Strandberg-Larsen M, Nielsen MB, Vallgårda S, Krasnik A, Vrangbæk K (2007) Denmark: health system review. Health Systems in Transition 9(6):29–30
Vallgård S, Krasnik A (2007) Health services and health policy. 1 udg. Gyldendal Akademisk, Copenhagen
Moller PK (2003) Pricing and reimbursement of drugs in Denmark. Eur J Health Econ 4(1):60–65
Norredam M, Mygind A, Nielsen AS, Bagger J, Krasnik A (2007) Motivation and relevance of emergency room visits among immigrants and patients of Danish origin. Eur J Public Health 17(5):497–502
Thomsen RW, Johnsen SP, Olesen AV, Mortensen JT, Boggild H, Olsen J et al (2005) Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol 60(5):534–542
Hempler NF, Diderichsen F, Larsen FB, Ladelund S, Jorgensen T (2010) Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study. Eur J Clin Pharmacol 66(7):735–742
Dominguez H, Schramm TK, Norgaard ML, Abildstrom SZ, Kober L, Jorgensen C et al (2009) Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications. Open Cardiovasc Med J 3:152–159
Rasmussen J, Rasmussen S, Gislason G, Buch P, Abildstrom S, Køber L (2006) Mortality after acute myocardial infarction according to income and education. J Epidemiol Community Health (60):351–356
Wallach Kildemoes H, Hendriksen C, Andersen M (2011) Drug utilization according to reason for prescribing: a pharmacoepidemiologic method based on an indication hierarchy. Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.2195
Thygesen LC, Daasnes C, Thaulow I, Bronnum-Hansen H (2011) Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 39[7 Suppl]:12–16
Kildemoes HW, Sorensen HT, Hallas J (2011) The Danish national prescription registry. Scand J Public Health 39[7 Suppl]:38–41
WHO Collaborating Centre for Drug Statistics Methodology (2010) Guidelines for ATC classification and DDD assignment 2011. WHO Collaborating Centre for Drug Statistics Methodology, Oslo
Hallas J, Gaist D, Bjerrum L (1997) The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization. Epidemiology 8(6):666–670
Langer O (2007) Oral anti-hyperglycemic agents for the management of gestational diabetes mellitus. Obstet Gynecol Clin North Am 34(2):255–274, ix
Uiters E, van Dijk L, Deville W, Foets M, Spreeuwenberg P, Groenewegen PP (2006) Ethnic minorities and prescription medication; concordance between self-reports and medical records. BMC Health Serv Res 6:115
Ringback WG, Ericsson O, Lofroth E, Rosen M (2008) Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden. Eur J Clin Pharmacol 64(4):417–424
Hall-Lipsy EA, Chisholm-Burns MA (2010) Pharmacotherapeutic disparities: racial, ethnic, and sex variations in medication treatment. Am J Health Syst Pharm 67(6):462–468
Bender DE, Clawson M, Harlan C, Lopez R (2004) Improving access for Latino immigrants: evaluation of language training adapted to the needs of health professionals. J Immigr Health 6(4):197–209
Michaelsen J, Krasnik A, Nielsen A, Norredam M, Torres AM (2004) Health professionals’ knowledge, attitudes, and experiences in relation to immigrant patients: a questionnaire study at a Danish hospital. Scand J Public Health 32(4):287–295
Dyhr L, Andersen JS, Engholm G (2007) The pattern of contact with general practice and casualty departments of immigrants and non-immigrants in Copenhagen, Denmark. Dan Med Bull 54(3):226–229
Hansen AR, Krasnik A, Hog E (2007) Access to health care for undocumented immigrants: rights and practice. Dan Med Bull 54(1):50–51
Norredam M (2011) Migrants’ access to healthcare. Dan Med Bull 58(10):B4339
Division of Primary Health Care Services, Norwegian Directorate of Health (2009) Migration and health—challenges and trends. Rapporter IS-1663E. Ministry of Health and Care Services, Oslo
Whitehead M (1992) The concepts and principles of equity and health. Int J Health Serv 22(3):429–445
Acknowledgements
The study was supported by a grant from the European Union under the Eramus Mundus scholarship scheme, through the Europubhealth program, and a grant from the Nordea Foundation supporting the Center for Healthy Aging. Access to data in Statistics Denmark as well as proofreading services were financed by the Center for Healthy Aging.
D.C.S-R and HWK designed the study, researched the data and wrote the manuscript. AK contributed to the discussions of the design and the analyses and reviewed the manuscript. HWK provided the elaborated database (in Statistics Denmark) applied in a previous study [25].
Competing interests
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sanchez-Ramirez, D.C., Krasnik, A. & Kildemoes, H.W. Do immigrants from Turkey, Pakistan and Ex-Yugoslavia with newly diagnosed type 2 diabetes initiate recommended statin therapy to the same extent as Danish-born residents? A nationwide register study. Eur J Clin Pharmacol 69, 87–95 (2013). https://doi.org/10.1007/s00228-012-1306-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-012-1306-6